|
BioVentures Investors LLC |
|
United States |
+1 (617) 252-3443 |
Series D |
|
|
|
BioVentures Investors LLC |
|
United States |
+1 (617) 252-3443 |
Series B |
|
|
|
BioVentures Investors LLC |
|
United States |
+1 (617) 252-3443 |
Series C |
|
|
|
Celgene Corp |
Biopharmaceutical company committed to improving the lives of patients worldwide. |
United States |
|
Series C |
|
|
|
Coastview Capital LLC |
|
United States |
|
Series B |
|
|
|
HBM BioVentures AG |
|
Switzerland |
+41 (41) 768-1108 |
Series D |
|
|
|
HBM BioVentures AG |
|
Switzerland |
+41 (41) 768-1108 |
Series C |
|
|
|
IngleWood Ventures |
|
United States |
+1 (858) 792-3579 |
Series A |
|
|
|
Lilly Ventures |
|
United States |
+1 (317) 651-3050 |
Series C |
|
|
|
Lilly Ventures |
|
United States |
+1 (317) 651-3050 |
Series D |
|
|
|
Mitsui & Co Global Investment Inc (三井グループ) |
|
United States |
|
Series C |
|
|
|
Mitsui & Co Global Investment Inc (三井グループ) |
|
United States |
|
Series D |
|
|
|
Mitsui & Co Global Investment Ltd (MCVP) |
|
Japan |
+86 (21) 5298-5959 |
Series B |
|
|
|
Morningside Group |
|
China |
+852 2894-9800 |
Series B |
|
|
|
Morningside Group |
|
China |
+852 2894-9800 |
Series D |
|
|
|
Novartis Services Inc (Novartis Venture Fund) |
|
United States |
+1 (617) 871-3536 |
N/A |
|
|
|
Novartis Services Inc (Novartis Venture Fund) |
|
United States |
+41 (61) 324-3714 |
N/A |
|
|
|
Novartis Venture Funds |
The corporate venturing arm of Novartis. |
Switzerland |
+41 (61) 324-6210 |
Series C |
|
|
|
Novartis Venture Funds |
The corporate venturing arm of Novartis. |
Switzerland |
+41 (61) 324-6210 |
Series D |
|
|
|
RCT BioVentures (Research Corporation Technologies BioVentures) |
The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies |
United States |
+1 (310) 824-1700 |
N/A |
|
|
|
RCT BioVentures (Research Corporation Technologies BioVentures) |
The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies |
United States |
+1 (310) 824-1700 |
Series C |
|
|
|
RCT BioVentures (Research Corporation Technologies BioVentures) |
The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies |
United States |
+1 (310) 824-1700 |
Series A |
|
|
|
Sanderling Ventures |
|
United States |
+1 (650) 401-2000 |
Series C |
|
|